Current coverage
Vivoryon Therapeutics N.V.
ISIN NL00150002Q7
Last updated: 17/11/2026
Conflicts of interest
- 5 MPCM or an affiliated company has reached an agreement with the analysed company on the compilation of the investment recommendation.
Recommendation history for the last 12 months
| First dissemination | Recommendation | Target price | Market closing price / observation time | Producer | Validity time period |
|---|---|---|---|---|---|
| 10/08/2026, 06:32 UTC | Buy | 6.85 EUR | 1.23 EUR (07/08/2026) | Felix Ellmann (Analyst) | 12M |
| 12/06/2026, 05:58 UTC | Buy | 6.85 EUR | 1.17 EUR (11/06/2026) | Felix Ellmann (Analyst) | 12M |
| 24/04/2026, 05:58 UTC | Buy | 7.5 EUR | 1.25 EUR (23/04/2026) | Felix Ellmann (Analyst) | 12M |
| 05/12/2025, 07:20 UTC | Buy | 7.5 EUR | 1.60 EUR (04/12/2025) | Felix Ellmann (Analyst) | 12M |
Share price and recommendation history
12/06/2023 – 16/11/2026 · FactSet daily closes for NL00150002Q7, EUR · Dashed line: target price; bar: recommendation.